• Mateon and PointR to merge into AI-driven oncology firm pharmaceutical-technology
    August 21, 2019
    Immuno-oncology company Mateon Therapeutics has signed a definitive agreement to merge with PointR Data, a computer and artificial intelligence (AI) company, to form an AI-driven firm focused on cancer treatment.
PharmaSources Customer Service